David P. Cormode

University of Pennsylvania

Papers

1

Total Citations

48

H-Index

1

About

David P. Cormode is a leading voice in nanomedicine, with a research focus that bridges advanced imaging, drug delivery, and the emerging field of nanozymes. His work is distinguished by its direct clinical relevance, particularly in addressing critical challenges in cardiovascular disease and infectious disease treatment. A prime example is his pioneering 2023 study on a "nanozyme-based robotics approach" for targeting fungal infections, which tackles the World Health Organization's highest-priority microbial threats by improving antifungal efficacy at the infection site while minimizing off-target effects and drug tolerance. This work, already garnering 48 citations, exemplifies his talent for engineering intelligent, theranostic nanoparticles that combine diagnostic imaging with therapeutic action. With a publication record that has amassed thousands of citations, Cormode’s contributions are foundational to the development of precision medicine. His notable achievements include developing novel contrast agents for atherosclerosis imaging and creating responsive nanomaterials that can be activated by the disease microenvironment, cementing his reputation as a translational scientist who is reshaping how we diagnose and treat complex diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Nanozyme‐Based Robotics Approach for Targeting Fungal Infection
48 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of Pennsylvania

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago